PTH and chronic obstructive pulmonary disease: Patients with parathyroid cancer often have severe hyperparathyroidism, and elevated serum parathyroid hormone (PTH) levels (> tenfold) [9, 10], which leads to marked hypercalcemia and clinical symptoms such as fatigue, bone complications, renal manifestations, and cardiac arrhythmia [11].